Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

207.00p
   
  • Change Today:
      8.00p
  • 52 Week High: 254.00
  • 52 Week Low: 176.60
  • Currency: UK Pounds
  • Shares Issued: 219.24m
  • Volume: 411,071
  • Market Cap: £453.83m
  • RiskGrade: 156
  • Beta: 0.02

AMS Overview

We are a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on value for our customers and quality outcomes for patients.
Competitors: Convatec Group, Consort Medical
Registrars: Capita Registrars

Key Personnel

CEO: A Christopher (Chris) Meredith
CFO: Eddie Johnson
Independent Non-Executive Director: Douglas Le Fort
Non-Executive Chairman: Grahame Cook
Non-Executive Dir: Susan Searle, Juliet Thompson

Contact Details

Address: Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, United Kingdom, CW7 3RT
Phone: +44 (0) 1606 863500
Fax: +44 (0) 1606 863600
Website: http://www.admedsol.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB0004536594

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 207.00p
Change Today 8.00p
% Change 4.02 %
52 Week High 254.00
52 Week Low 176.60
Volume 411,071
Shares Issued 219.24m
Market Cap £453.83m
Beta 0.02
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.44% below the market average92.44% below the market average92.44% below the market average92.44% below the market average92.44% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average
Price Trend
49.52% below the market average49.52% below the market average49.52% below the market average49.52% below the market average49.52% below the market average
2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average
Income
84.85% below the market average84.85% below the market average84.85% below the market average84.85% below the market average84.85% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Growth
17.67% below the market average17.67% below the market average17.67% below the market average17.67% below the market average17.67% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

What The Brokers Say

Strong Buy 4
Buy 4
Neutral 0
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 19-Jun-25 26-Sep-24
Paid 17-Jul-25 25-Oct-24
Amount 1.83p 0.77p

Trades for 17-Jul-2025

Time Volume / Share Price
16:35 139 @ 207.00p
16:35 37 @ 207.00p
16:35 327 @ 207.00p
16:35 91 @ 207.00p
16:35 2,046 @ 207.00p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson

Top of Page